FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
The new FDA approval gives Daiichi Sankyo’s Turalio some company in a rare tumor type.
The new FDA approval gives Daiichi Sankyo’s Turalio some company in a rare tumor type.
